Skip Navigation

Co-Chair Bios

Jonathan S. Lewin, MD
Co-Chair, Blue Ridge Academic Health Group
Executive Vice President for Health Affairs, Emory University
Executive Director, Woodruff Health Sciences Center
President, CEO, and Chairman of the Board, Emory Healthcare 

Jeffrey Balser

Jonathan Lewin, MD, is currently the Executive Vice President for Health Affairs, Emory University; Executive Director, Woodruff Health Sciences Center; and the President, CEO and Chairman of the Board, Emory Healthcare.  He also serves as Professor of Radiology and Imaging Sciences and Professor of Biomedical Engineering in the School of Medicine and Professor of Health Policy and Management in the Rollins School of Public Health.

Prior to his Emory appointment, Dr. Lewin served as the Martin Donner Professor and Chairman of the Russell H. Morgan Department of Radiology and Radiological Science at Johns Hopkins University and the Radiologist-in-Chief at Johns Hopkins Hospital from 2004 until 2016, with secondary appointments as Professor of Oncology, Neurosurgery and Biomedical Engineering. From 2012-2016 he also served as Co-Chair for Strategic Planning and from 2013-2016 as Senior Vice President for Integrated Healthcare Delivery for Johns Hopkins Medicine.

Before joining the faculty of Johns Hopkins, Dr. Lewin was the Director of the Division of Magnetic Resonance Imaging at University Hospitals of Cleveland and Professor and Vice Chairman for Research and Academic Affairs in the Department of Radiology at Case Western Reserve University.

Dr. Lewin received his undergraduate degree in chemistry from Brown University in 1981 and his Doctor of Medicine from Yale University in 1985. Following his internship in pediatrics at Yale-New Haven Hospital and residency in diagnostic radiology at University Hospitals of Cleveland, he completed a magnetic resonance research fellowship in Germany, a neuroradiology fellowship at the Cleveland Clinic, and additional training in head and neck radiology at the Pittsburgh Eye and Ear Hospital.

Dr. Lewin has been a pioneer in interventional and intraoperative MR imaging and has published more than 200 peer-reviewed scientific manuscripts and 60 book chapters, reviews, commentaries and other invited papers on topics including the basic science and clinical aspects of interventional MR imaging, functional MR imaging, head and neck imaging, MR angiography, small animal imaging and the imaging of acute stroke.

Dr. Lewin is an inventor on more than 25 patents, and has been PI or co-PI on NIH and other federal and state grants with awards of more than 10 million dollars, as well as a co-investigator on a number of other grants and projects. He is a Fellow of the International Society for Magnetic Resonance in Medicine and of the American College of Radiology, and has given more than 200 invited lectures on a number of topics in magnetic resonance imaging, interventional radiology, neuroradiology, and leadership in academic medicine. He has served on numerous national committees, editorial boards and grant review groups for foundations and the NIH, and on the task force on minimally invasive cancer therapy for the National Cancer Institute.

Dr. Lewin currently serves as president of the Society of Chairs of Academic Radiology Departments, and previously served as president of the American Roentgen Ray Society, the Association of University Radiologists, the International Society for Strategic Studies in Radiology, and the Academy for Radiology Research.

Jeffrey R. Balser, MD, PhD
Co-Chair, Blue Ridge Academic Health Group
President and CEO, Vanderbilt University Medical Center
Dean, Vanderbilt University School of Medicine

Jon Lewin

Dr. Jeffrey R. Balser is currently President and CEO of Vanderbilt University Medical Center (VUMC), reporting to an independent board of directors. He is also dean of Vanderbilt University School of Medicine, a position he has held since 2008.

Dr. Balser joined Vanderbilt in 1998 and has served as a change agent in a number of roles since that time. In 2009, he was named Vice Chancellor for Health Affairs, with executive responsibility for all health-related programs, including the hospitals, clinics, research programs, and the medical and nursing schools. He led the medical center through a period of marked service-volume growth, with major inpatient expansions of the children's hospital and the adult critical care areas, bolstered by 4% compound annual growth of outpatient visits (more than 2.1 million per year) and by the creation of region's largest, multi-state provider-led network (more than 50 hospitals and 3000 clinicians: the Vanderbilt Health Affiliated Network). In 2013-2014, he led a $230 million (8%) cost reduction across all mission areas, improving the medical center's competitive position in a rapidly evolving, price-sensitive marketplace. In coordination with the Vanderbilt Chancellor and Board of Trustees, Dr. Balser led the medical center through a restructuring process that concluded April 30, 2016, placing its clinicians, hospitals, clinics, and research and graduate medical education programs into a financially distinct, not-for-profit corporation, Vanderbilt University Medical Center.

A Vanderbilt alumnus, Dr. Balser returned to Vanderbilt in 1998 as Associate Dean for Physician Scientist Development, and soon was appointed Chair of the Department of Anesthesiology, directing one of the medical center's largest clinical service programs. He became the medical center's chief research officer in 2004, leading a period of scientific expansion that moved the medical center into the nation's top 10 in NIH funding, launching big-science programs integrating health informatics and genomics that stimulated the medical center's national leadership in personalized medicine. In 2008 he was elected to the National Academy of Medicine and later that year was named the 11th dean of Vanderbilt's School of Medicine. 

Dr. Balser received a B.S. in engineering from Tulane University in 1984 and his MD/PhD degrees (pharmacology) from Vanderbilt University in 1990. He undertook residency training in anesthesiology and fellowship training in cardiac anesthesiology and in critical care medicine at The Johns Hopkins Hospital in Baltimore. He joined the faculty at Johns Hopkins in 1995, where he practiced cardiac anesthesiology and ICU medicine and led an NIH-funded research program aimed at the genetics of cardiac rhythm disorders, such as sudden cardiac death.